Quantcast
Last updated on April 18, 2014 at 5:48 EDT

Latest Hologic Inc. Stories

2013-07-23 16:24:15

The addition of Hologic's Aptima HPV assay to the fully-automated Panther system expands the ability of laboratories to run multiple tests from a single specimen. BEDFORD, Mass., July 23, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, announced today that the U.S. Food and...

2013-07-22 08:31:52

HONG KONG, July 22, 2013 /PRNewswire/ -- Pennystocksinsiders.com (PSI) released insider trading reports for investors as tool to trace the following active stocks and penny stocks: Johnson & Johnson (NYSE:JNJ), Hologic (NASDAQ:HOLX), Alcoa (NYSE:AA), Pitney Bowes (NYSE:PBI), KeyCorp (NYSE:KEY), and Health Management Associates (NYSE:HMA). (Logo: http://photos.prnewswire.com/prnh/20130717/HK48549LOGO ) (Read full report by clicking the link below, you may need to copy and paste...

2013-07-18 16:26:06

Robert Cascella Will Remain Advisor to Company Through November 2013 BEDFORD, Mass., July 18, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, announced today Jack W. Cumming has been named President and Chief Executive Officer, effective immediately. Mr. Cumming joined...

2013-07-15 16:23:57

Prone and upright guidance systems, biopsy device utilizing 3D, stereotactic, ultrasound or MRI guidance, site markers and specimen radiography from a single vendor BEDFORD, Mass., July 15, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, recently expanded its extensive...

2013-07-05 08:21:16

NEW YORK, July 5, 2013 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Today, Wall Street Reports announced new research reports highlighting Medtronic, Inc. (NYSE: MDT), Stryker Corp. (NYSE: SYK), Hologic Inc. (NASDAQ: HOLX), ResMed Inc. (NYSE: RMD) and Align Technology Inc. (NASDAQ: ALGN). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via...

2013-06-26 08:31:55

BEDFORD, Mass., June 26, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced plans to release its third quarter fiscal 2013 operating results on Monday, August 5, 2013, after market close. In conjunction with the release, management will host a conference call on...

2013-06-06 12:29:29

Collaboration features national availability of the APTIMA HPV mRNA-based cervical cancer screening test as well as a focus on developing and expanding access to diagnostic solutions for women's health MADISON, N.J. and BEDFORD, Mass., June 6, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading diagnostic information services company, and Hologic, Inc. (Hologic) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical...

2013-06-03 16:27:07

QUEBEC CITY, June 3, 2013 /PRNewswire/ - DiagnoCure Inc. (TSX: CUR) (OTCQX: DGCRF) (the "Corporation") today reported financial and operational results for the second quarter ended April 30, 2013. The Corporation announced a net loss of $849,344 or $0.02 per share for this quarter. At the end of the quarter, cash and short-term investments stood at $4,849,305. Second Quarter Highlights On April 2, 2013, the Corporation initiated trading on OTCQX( )International under the symbol...

2013-05-23 12:27:04

New study builds on significant body of evidence showing improved results using Hologic's 3D mammogram for breast cancer screening BEDFORD, Mass., May 23, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced that the first large-scale observational study in a U.S....

2013-05-21 08:29:28

BEDFORD, Mass., May 21, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced that the U.S. Food and Drug Administration (FDA) approved the use of Hologic's new C-View 2D imaging software. C-View 2D images may now be used in place of the conventional 2D exposure previously required...